Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Mulpleta Tablets 3mg drug use-results survey

Trial Profile

Mulpleta Tablets 3mg drug use-results survey

Status: Recruiting
Phase of Trial: Phase IV

Latest Information Update: 05 Aug 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Lusutrombopag (Primary)
  • Indications Thrombocytopenia
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Shionogi
  • Most Recent Events

    • 29 Jul 2022 Results of a pooled analysis (JapicCTI-163289, NCT02389621 and JapicCTI-163432 studies) assessing the pharmacokinetics, efficacy, and safety of lusutrombopag in patients with Child-Pugh class C chronic liver disease published in the Advances in Therapy
    • 01 Oct 2019 Results (data cut off: Sep 2018) published in the Hepatology Research
    • 16 Nov 2016 New trial record
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top